Science news and articles on health, environment, global warming, stem cells, bird flu, autism, nanotechnology, dinosaurs, evolution -- the latest discoveries in astronomy, anthropology, biology, chemistry, climate & bioengineering, computers, engineering ; medicine, math, physics, psychology, technology, and more from the world's leading research centers universities.

Toward a better sweat test for babies with cystic fibrosis

0

Cystic fibrosis (CF) is an incurable genetic disease in which patients have chronic lung infections. The sooner CF is diagnosed, the better the symptoms can be managed. But current tests can give ambiguous results that do not reflect disease progression. Today, in ACS Central Science, researchers reveal a new type of sweat test that can overcome this challenge.

Patients with CF have a genetic mutation that promotes mucus buildup and enables biofilms to form in their lungs, leading to frequent lung infections and breathing difficulty. In addition, chloride ions accumulate in these patients, and they excrete this as a "salty" sweat. Physicians have used this interesting effect to develop a sweat test for CF diagnosis. However, the test does not provide any staging or prognostic information and often fails in borderline cases. Most people with the gene (more than 70 percent) are "carriers" who don't develop the disease, so a genetic test alone is also not sufficient to diagnose CF. Philip Britz-McKibbin and colleagues hypothesized that there could be other molecules found in sweat that would provide the basis for a better test.

The researchers profiled the chemical composition of sweat from screen-positive infants including both unaffected carriers and confirmed CF cases. They identified several unknown chemicals in sweat that were consistently associated in babies who had CF, in addition to chloride. The researchers suggest that testing for these alternative molecules could be done for cases in which the chloride sweat test is too close to call. They also intend to track the progression of CF and monitor treatment responses to therapy in children using these and other sweat molecules.

###

The authors acknowledge funding from Cystic Fibrosis Canada, the Natural Sciences and Engineering Research Council of Canada, the Canada Foundation for Innovation and McMaster University.

The paper will be freely available on July 31, 2017, at 8 a.m. Eastern time at this link: http://pubs.acs.org/doi/full/10.1021/acscentsci.7b00299

The American Chemical Society, the world's largest scientific society, is a not-for-profit organization chartered by the U.S. Congress. ACS is a global leader in providing access to chemistry-related information and research through its multiple databases, peer-reviewed journals and scientific conferences. ACS does not conduct research, but publishes and publicizes peer-reviewed scientific studies. Its main offices are in Washington, D.C., and Columbus, Ohio.

To automatically receive news releases from the American Chemical Society, contact [email protected]

Follow us: Twitter | Facebook

Media Contact

Katie Cottingham
[email protected]
301-775-8455
@ACSpressroom

http://www.acs.org

Leave A Reply

Your email address will not be published.